D. C. Kahraman Et Al. , "Sequential treatment of HCC cells with PI3K/Akt/mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population," EUROPEAN JOURNAL OF CANCER , vol.61, 2016
Kahraman, D. C. Et Al. 2016. Sequential treatment of HCC cells with PI3K/Akt/mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population. EUROPEAN JOURNAL OF CANCER , vol.61 .
Kahraman, D. C., Kahraman, T., & ATALAY, R., (2016). Sequential treatment of HCC cells with PI3K/Akt/mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population. EUROPEAN JOURNAL OF CANCER , vol.61.
Kahraman, D., T. Kahraman, And RENGÜL ATALAY. "Sequential treatment of HCC cells with PI3K/Akt/mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population," EUROPEAN JOURNAL OF CANCER , vol.61, 2016
Kahraman, D. C. Et Al. "Sequential treatment of HCC cells with PI3K/Akt/mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population." EUROPEAN JOURNAL OF CANCER , vol.61, 2016
Kahraman, D. C. Kahraman, T. And ATALAY, R. (2016) . "Sequential treatment of HCC cells with PI3K/Akt/mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population." EUROPEAN JOURNAL OF CANCER , vol.61.
@article{article, author={D. C. Kahraman Et Al. }, title={Sequential treatment of HCC cells with PI3K/Akt/mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population}, journal={EUROPEAN JOURNAL OF CANCER}, year=2016}